In a groundbreaking development, the recent trials of a drug developed by Ireland-based psychedelics biotech company GH Research have showcased its potential in treating treatment-resistant depression. The mid-stage clinical trial, comprising 81 participants, revealed a significant reduction in
In the rapidly evolving landscape of biopharmaceutical manufacturing, capturing real-time data has become pivotal in optimizing bioreactor performance and producing high-quality products. Inline monitoring technologies are at the forefront of this transformation, offering real-time surveillance and
The cell culture media market is experiencing a significant surge, driven by technological advancements and increased investments in research and development (R&D). These media are crucial for the growth, proliferation, and maintenance of various cell types, including microbial cells and stem
The biopharmaceutical industry is undergoing a significant transformation, driven by the need to develop and market novel therapies more quickly and cost-effectively. At the forefront of this revolution is WuXi Biologics, leveraging advanced Process Analytical Technology (PAT) to enhance real-time
Imagine a world where the devastating effects of Alzheimer's disease can be reversed through an innovative new drug. This scenario may soon become a reality, thanks to groundbreaking research from the Centre for Addiction and Mental Health (CAMH). The study investigates the impact of GL-II-73,
The search for effective treatments for Parkinson's disease has been long and arduous, with researchers globally dedicating countless hours to uncover potential therapies. One promising candidate, exenatide, a GLP-1 drug traditionally used to treat Type 2 diabetes, recently underwent scrutiny
